Entrar Registro gratuito

NeuroVive Pharmaceutical AB Propriedade institucional

Qual é o Propriedade institucional de NeuroVive Pharmaceutical AB?

O Propriedade institucional de NeuroVive Pharmaceutical AB é 48.96%

Qual é a definição de Propriedade institucional?



Propriedade Institucional é a quantidade de ações disponíveis de uma empresa pertencentes a fundos mútuos ou de pensão, seguradoras, empresas de investimento, doações ou outras grandes entidades que administram fundos em nome de terceiros.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Propriedade institucional de empresas na Setor Health Care em OTC em comparação com NeuroVive Pharmaceutical AB

O que NeuroVive Pharmaceutical AB faz?

Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Empresas com propriedade institucional semelhantes a NeuroVive Pharmaceutical AB